Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies. [electronic resource]
Producer: 20190314Description: 847-855 p. digitalISSN:- 1873-7560
- Aged
- Androgen Antagonists -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Neoplasms -- secondary
- Clinical Trials, Phase III as Topic
- Docetaxel -- administration & dosage
- Gonadotropin-Releasing Hormone -- agonists
- Humans
- Male
- Middle Aged
- Neoplasm Metastasis
- Orchiectomy
- Prognosis
- Prostatic Neoplasms -- pathology
- Randomized Controlled Trials as Topic
- Survival Rate
- Tumor Burden
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.